Real-time enrollment status for this neurofibromatosis type 1 clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 12:10 AM UTC
| NCT Number | NCT06880991 |
| Recruiting Status | Recruiting |
| Condition | Neurofibromatosis Type 1 |
| Phase | Clinical Trial |
| Target Enrollment | 110 participants |
| Active Locations | 1 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | April 29, 2026 (Apr 29, 2026) |
As of July 18, 2026: Clinical trial NCT06880991 is currently recruiting participants. This clinical trial study for neurofibromatosis type 1 is actively seeking new participants at 1 location across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06880991 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06880991 was last updated Apr 29, 2026 (April 29, 2026). HelloStudys verifies this status automatically.